Cargando…
Loss of Sparc in p 53‐null Astrocytes Promotes Macrophage Activation and Phagocytosis Resulting in Decreased Tumor Size and Tumor Cell Survival
Both the induction of SPARC expression and the loss of the p53 tumor suppressor gene are changes that occur early in glioma development. Both SPARC and p53 regulate glioma cell survival by inverse effects on apoptotic signaling. Therefore, during glioma formation, the upregulation of SPARC may coope...
Autores principales: | Thomas, Stacey L., Schultz, Chad R., Mouzon, Ezekiell, Golembieski, William A., Naili, Reima El, Radakrishnan, Archanna, Lemke, Nancy, Poisson, Laila M., Gutiérrez, Jorge A., Cottingham, Sandra, Rempel, Sandra A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4520390/ https://www.ncbi.nlm.nih.gov/pubmed/24862407 http://dx.doi.org/10.1111/bpa.12161 |
Ejemplares similares
-
SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion
por: Yunker, Christopher K, et al.
Publicado: (2008) -
Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival
por: Schultz, Chad R, et al.
Publicado: (2012) -
Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
por: Arnold, Shanna A., et al.
Publicado: (2012) -
Chronic spinal cord compression associated with intervertebral disc degeneration in SPARC-null mice
por: Li, Zhuo-Yao, et al.
Publicado: (2022) -
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
por: Chlenski, Alexandre, et al.
Publicado: (2010)